Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G Matinas BioPharma Holdin Filed by: Hezbay Holdings LLC

July 14, 2026 3:44 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Note to 6, 8, 9 and 11: Based on 13,692,796 Common Shares issued and outstanding as of July 10, 2026. Note to 10: The aggregate amount in Row 9 excludes the Common Shares purchasable pursuant to the Preferred Shares and Warrants owned by the Reporting Person which contain a contractually stipulated 4.99% ownership restriction.


SCHEDULE 13G



Hezbay Holdings LLC
Signature:/s/ Ari Kluger
Name/Title:Ari Kluger, Sole Member of Hezbay Holdings LLC
Date:07/14/2026

Categories

SEC Filings